Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This proposed study seeks to community knowledge and understand the experience of underserved communities in the exploration of reducing health disparities and increasing vaccine uptake and acceptability COVID-19, influenza, and pneumonia for AA and Latinx populations. Unique in its design, it has the following characteristics: 1) multifaceted, 2) culturally tailored, 3) community-based, and 4) mixed methods in which the outcomes of interest will be measured before and after the intervention with 18-month interval. Furthermore, we seek to enhance our partnerships and collaborations with churches in South Los Angeles by supporting efforts to encourage COVID-19, influenza, and pneumonia vaccination uptake among underserved minorities in one of the most challenged and hard-to-reach population areas in the nation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children

NCT05613751

Influenza COVID-19

RECRUITING NA

Validation of Promising Biomarker Assays to Assess Their Diagnostic Performance Characteristics

NCT03047642

Acute Febrile Illnesses

COMPLETED

Communities Fighting COVID-19!

NCT05148936

Covid19

COMPLETED NA

Pneumococcal Carriage in Patients With Lower Respiratory Tract Infection (LRTI)

NCT01861184

Lower Respiratory Tract Infections

COMPLETED

The Impact of SARS-CoV-2 Rapid Antigen Testing Kit Screening in Bangkok Community

NCT05047900

Covid19 SARS-CoV-2 Community Transmissions +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study seeks to augment community knowledge and increase vaccine uptake among under-resourced African American and Latinx communities in South LA via leveraging trusted church leaders, educators and influencers to delivering COVID-19, influenza, and pneumonia education on vaccination. Unique in its design, this study has the following characteristics, beneficial to the acceptability and success of the proposal, it is: 1) multifaceted, 2) culturally tailored, and 3) community-based, in which the outcomes of interest will be compared longitudinally between arms 1-3, including measurement before and after the intervention with 9- and 18-month interval.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19 Influenza Pneumonia Vaccine Refusal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The VEPMP will consist of recruited churches in 15 cohorts of 2 churches per cohort (total n = 30). Each cohort of church will include an AA and a Latinx church. The 15 church cohorts will be randomized to three arms based on a 1:1:1 ratio, using an online random number generator.

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1

This arm will include 5 churches who will receive all study activities in the Vaccine Education Promotion Management Plan

Group Type EXPERIMENTAL

Full VEPMP Intervention

Intervention Type BEHAVIORAL

Delivery of intrapersonal/interpersonal (i.e., motivational interviewing, vaccine educators, personal testimony, etc.), AND organizational (i.e., church-based sponsored events, seminars, web/online activities, bulletin inserts, etc.)

Arm 2

This arm will include 5 churches who will receive some study activities in the Vaccine Education Promotion Management Plan

Group Type EXPERIMENTAL

Partial VEPMP Intervention

Intervention Type BEHAVIORAL

Delivery of iAND organizational (i.e., church-based sponsored events, seminars, web/online activities, bulletin inserts, etc.)

Arm 3

This arm will include 5 churches who will receive all study activities in the Vaccine Education Promotion Management Plan following completion of Arm 1 and 2.

Group Type EXPERIMENTAL

Delayed VEPMP Intervention

Intervention Type BEHAVIORAL

Delayed implementation of delivery of intrapersonal/interpersonal AND organizational after 1 year of study start

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Full VEPMP Intervention

Delivery of intrapersonal/interpersonal (i.e., motivational interviewing, vaccine educators, personal testimony, etc.), AND organizational (i.e., church-based sponsored events, seminars, web/online activities, bulletin inserts, etc.)

Intervention Type BEHAVIORAL

Partial VEPMP Intervention

Delivery of iAND organizational (i.e., church-based sponsored events, seminars, web/online activities, bulletin inserts, etc.)

Intervention Type BEHAVIORAL

Delayed VEPMP Intervention

Delayed implementation of delivery of intrapersonal/interpersonal AND organizational after 1 year of study start

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Parishioner at a church receiving the VEPMP intervention
* Identify as African American or Latinx,
* at least 65 years and older
* Have Not received a vaccine for COVID-19, influenza, or pneumonia within the previous 24 months
* Agrees to study terms, which include follow-up interviews 9 and 18 months after study enrollment

Exclusion Criteria

* Does not attend or identify as a Parishioner at a church receiving the VEPMP intervention
* Does not identify as African American or Latinx
* Under the age of 65 years
* Received all vaccine doses for COVID-19, influenza, or pneumonia within the previous 24 months

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes